Using the Pathfinder system to reduce missed abnormal cervical cytologic smear cases in a rescreening program

Area of Science:

• Cytopathology
• Medical Technology
• Quality Assurance

Background:

• Cervical cancer screening relies on accurate cytologic smear analysis.
• False negative results in cervical cytology can lead to delayed diagnosis and treatment.
• Process control in cytology screening is crucial for maintaining high diagnostic accuracy.

Purpose of the Study:

• To evaluate the impact of the Pathfinder instrument on the false negative rate of cervical cytologic smears.
• To assess the effectiveness of Pathfinder in improving the quality assurance of cervical cancer screening.

Main Methods:

• The Pathfinder instrument was implemented in a large cytology laboratory.
• Cytotechnologists used Pathfinder to monitor screening time, slide area, and field overlap.
• A random 10% of negative cases were rescreened to determine missed abnormal cases before and after Pathfinder implementation.

Main Results:

• A significant decrease in missed abnormal cervical cytologic smear cases was observed.
• The false negative rate for atypical cells of undetermined significance (ASCUS) decreased by 56%, from 1.6% to 0.7%.
• The study period was nine months, with a focus on ASCUS detection rates.

Conclusions:

• The Pathfinder system's continuous feedback and process standardization led to a reduction in missed abnormal cases.
• The primary driver of this improvement was a marked decrease in missed ASCUS cases.
• Pathfinder offers valuable management tools for ensuring consistent, high-quality cervical screening.